earnings
confidence high
sentiment positive
materiality 0.75
Medpace Q1 revenue up 27.3% to $330.9M; EPS $1.69 vs $1.14 YoY
Medpace Holdings, Inc.
2022-Q1 EPS reported
$1.69
revenue$330,947,000
- Revenue $330.9M, +27.3% YoY; constant-currency organic growth +28.1%.
- GAAP EPS $1.69 diluted vs $1.14 prior year; net income margin 18.5% (prev 16.7%).
- Net new business awards $423.0M (+18.8% YoY); book-to-bill ratio 1.28x.
- Backlog grew 28.0% to $2.1B from $1.6B as of Mar 31, 2021.
- EBITDA $70.4M (+31.3%); margin 21.3% vs 20.6% prior year.